Fingerprint
Dive into the research topics of 'Long-term follow-up of patients with hypereosinophilic syndrome treated with alemtuzumab, an anti-CD52 antibody'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Long-term follow-up of patients with hypereosinophilic syndrome treated with alemtuzumab, an anti-CD52 antibody
Paolo Strati, Jorge Cortes, Stefan Faderl, Hagop Kantarjian, Srdan Verstovsek
Research output: Contribution to journal › Article › peer-review
36
Scopus
citations